FDA Review Skeptical of ALS Stem Cell Therapy FDA Review Skeptical of ALS Stem Cell Therapy

The FDA has raised concerns about the safety and efficacy of an experimental stem cell therapy for ALS scheduled for a public hearing by a federal advisory panel on Wednesday.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news